298 top medical experts on Congenital Myasthenic Syndromes across 47 countries and 23 U.S. states, including 122 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Congenital Myasthenic Syndromes: A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the neuromuscular junction. This includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (receptors, nicotinic) on the postsynaptic surface of the junction. (From Arch Neurol 1999 Feb;56(2):163-7)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Genetic Diseases (2,477), Neuromuscular Junction Diseases (427).
  4. Clinical Trials ClinicalTrials.gov : at least 11 including 4 Completed, 1 Recruiting
  5. Synonyms: Congenital Slow-Channel Myasthenic Syndrome,  Slow Channel Congenital Myasthenic Syndromes,  Postsynaptic Congenital Myasthenic Syndrome,  Presynaptic Congenital Myasthenic Syndrome,  Slow-Channel Congenital Myasthenic Syndrome


  

        

                    


    Computing Expert Listing ...

);